Undertreatment of Older Patients with Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies

With the expanding armamentarium of therapeutic agents in multiple myeloma (MM), it is important to identify any undertreated patient populations to mitigate outcome disparities.

Source: Clinical Lymphoma, Myeloma and Leukemia - February 3, 2018 Category: Hematology Authors: Bita Fakhri, Mark A. Fiala, Sascha A. Tuchman, Tanya M. Wildes Tags: Original Study Source Type: research